Cargando…
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance
The European LeukemiaNet MDS (EUMDS) registry is collecting data of myelodysplastic syndrome (MDS) patients belonging to the IPSS low or intermediate-1 category, newly diagnosed by local cytologists. The diagnosis of MDS can be challenging, and some data report inter-observer variability with regard...
Autores principales: | de Swart, Louise, Smith, Alex, MacKenzie, Marius, Symeonidis, Argiris, Neukirchen, Judith, Mikulenková, Dana, Vallespí, Teresa, Zini, Gina, Paszkowska-Kowalewska, Malgorzata, Kruger, Anton, Saft, Leonie, Fenaux, Pierre, Bowen, David, Hellström-Lindberg, Eva, Čermák, Jaroslav, Stauder, Reinhard, Tatic, Aurelia, Holm, Mette Skov, Malcovati, Luca, Mądry, Krzysztof, Droste, Jackie, Blijlevens, Nicole, de Witte, Theo, Germing, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486793/ https://www.ncbi.nlm.nih.gov/pubmed/28526957 http://dx.doi.org/10.1007/s00277-017-3009-7 |
Ejemplares similares
-
Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective
por: de Witte, Theo, et al.
Publicado: (2020) -
Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study
por: Stauder, Reinhard, et al.
Publicado: (2018) -
P731: SURVIVAL IN LOWER-RISK MDS PATIENTS FROM EUMDS REGISTRY BY TWO TRANSPLANT SELECTION CRITERIA - IMPLICATIONS FOR TRANSPLANT DECISION
por: Savic, Aleksandar, et al.
Publicado: (2023) -
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry
por: Hoeks, Marlijn, et al.
Publicado: (2020) -
Development of a core outcome set for myelodysplastic syndromes – a Delphi study from the EUMDS Registry Group
por: Rochau, Ursula, et al.
Publicado: (2020)